Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renaissance Pharmaceuticals (primarily Renaissance Lakewood LLC / Renaissance Pharma, Inc.) is a US-based CDMO specializing in nasal sprays and sterile injectables, acquired by LTS in November 2025. It was previously backed by RoundTable Healthcare Partners (founded 2010, ~500 employees, $169M revenue). It focuses on contract manufacturing for pharma/biotech clients, not internal drug development. A separate UK entity 'Renaissance Pharma Ltd.' develops an anti-GD2 antibody (Hu14.18K322A) for neuroblastoma (Phase II complete), but no confirmed relation to the queried name or the US company. No exact match for 'Renascence Pharmaceuticals'; closest is 'Renaissance Pharmaceuticals' variants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renascense Pharmaceuticals.